Look for:

Our offer for

AMGEN INC.


ISIN:
US0311621009
WKN:
031162100

2020/07/14 22:00:00
Price
253.09 USD
Difference 1.22% (3.05)

General attributes

ISINUS0311621009
SymbolAMGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)131,180 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)248.56 USD (100)
Ask (Ask size)257.13 USD (100)
Open242.76 USD
High253.79 USD
Low240.48 USD
Close (prev. day)250.04 USD
VWAP249.922131 USD
Volume (pcs)2,368,342
Trading volume591,352,071.18
Number of trades35,129
Last size382,152

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: AMGEN INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2020/07/14 22:00:00
Price
253.09 USD
Difference 1.22% (3.05)

General attributes

ISINUS0311621009
SymbolAMGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)131,180 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)248.56 USD (100)
Ask (Ask size)257.13 USD (100)
Open242.76 USD
High253.79 USD
Low240.48 USD
Close (prev. day)250.04 USD
VWAP249.922131 USD
Volume (pcs)2,368,342
Trading volume591,352,071.18
Number of trades35,129
Last size382,152

Performance and Risk

6m1Y3Y
Perf (%)+5.45%+44.68%+42.88%
Perf (abs.)+13.09+78.16+75.96
Beta0.780.760.82
Volatility47.8836.8127.50
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)251.08 USD (1,991,211)
Ø price 30 days | Ø volume 30 days (pcs.)235.45 USD (2,827,122)
Ø price 100 days | Ø volume 100 days (pcs.)223.41 USD (3,257,196)
Ø price 250 days | Ø volume 250 days (pcs.)217.64 USD (2,844,092)
YTD High | date264.97 USD (2020/07/06)
YTD Low | date177.05 USD (2020/03/23)
52 Weeks High | date264.97 USD (2020/07/06)
52 Weeks Low | date173.12 USD (2019/07/26)

All listings for AMGEN INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2020/07/1511:29221.15 EUR0.0611
Vienna Stock Exchange2020/07/1509:20222.30 EUR0.002
Tradegate2020/07/1511:31221.55 EUR0.0613
Stuttgart2020/07/1509:29221.95 EUR0.002
SIX Swiss Exchange2019/06/2717:35184.90 USD0.002
Nasdaq2020/07/1422:00253.09 USD591.3535,129
Munich2020/07/1508:44221.35 EUR0.002
London Stock Exchange2020/07/1417:35248.65 USD0.076
Hong Kong Stock Exchange2018/04/2804:111,000.00 HKD--
Hanover2020/07/1508:06221.75 EUR0.001
Hamburg2020/07/1508:06221.75 EUR0.001
Frankfurt2020/07/1509:46220.70 EUR0.003
Duesseldorf2020/07/1511:30220.20 EUR0.002
Borsa Italiana MTF Trading After Hours2020/06/2419:12206.00 EUR0.001
Borsa Italiana MTF Global Equity Market2020/07/1510:52220.70 EUR0.012
Berlin2020/07/1508:08221.70 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1823&ID_TYPE_IMAGE_LOGO=2

Contact Details

AMGEN INC.
- -
One Amgen Center Drive - 91320-1799 Thousand Oaks, CA
Telefon: +1-805-447-1000
Fax: +1-805-447-1010
E-mail: investor.relations@amgen.com

PDF Downloads

Company report: AMGEN INC.PDF Download

Company Profile

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Members of Management Board

Robert A. BradwayChairman of Board of Directors
Wanda M. AustinMember of Board of Directors
Tyler JacksMember of Board of Directors
Ronald D. SugarMember of Board of Directors
Robert A. EckertMember of Board of Directors
Rebecca M. HendersonMember of Board of Directors
R. Sanders WilliamsMember of Board of Directors
Greg C. GarlandMember of Board of Directors
Fred HassanMember of Board of Directors
Ellen J. KullmanMember of Board of Directors
Charles M. Holley Jr.Member of Board of Directors
Brian J. DrukerMember of Board of Directors
Robert BradwayChairman of Managing Board
Victoria H. BlatterMember of Executive Committee
Tia BushMember of Executive Committee
Susan SweeneyMember of Executive Committee
Steven K. GalsonMember of Executive Committee
Raymond DeshaiesMember of Executive Committee
Peter H. GriffithMember of Executive Committee
Murdo GordonMember of Executive Committee
Mike ZahigianMember of Executive Committee
Mike NohaileMember of Executive Committee
Lori JohnstonMember of Executive Committee
Judy Gawlik BrownMember of Executive Committee
Jonathan GrahamMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer